opthea.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: | ||
Meta Tags
| Title | Opthea | Opthea Developing Therapy for Eye |
| Description | Investigating Anti-VEGF-C and -D Therapy in OPT-302 helps to block vascular growth factors which cause blood vessels to leak that lead to eye |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.206.117.137 |
| Location | Australia |
Related Websites
| Site | Rank |
More to Explore
opthea.com Valuation
|
US$4,546,052
Last updated: 2023-04-29 11:08:19
opthea.com has Semrush global rank of 2,328,241. opthea.com has an estimated worth of US$ 4,546,052, based on its estimated Ads revenue. opthea.com receives approximately 524,545 unique visitors each day. Its web server is located in Australia, with IP address 54.206.117.137. According to SiteAdvisor, opthea.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,546,052 |
| Daily Ads Revenue | US$4,197 |
| Monthly Ads Revenue | US$125,891 |
| Yearly Ads Revenue | US$1,510,688 |
| Daily Unique Visitors | 34,970 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| opthea.com. | A | 3600 | IP: 54.206.117.137 |
| opthea.com. | NS | 3600 | NS Record: ns3.m21dns.net. |
| opthea.com. | NS | 3600 | NS Record: ns2.m21dns.net. |
| opthea.com. | NS | 3600 | NS Record: cp-kil-m-001.m21dns.net. |
| opthea.com. | NS | 3600 | NS Record: ns4.m21dns.net. |
| opthea.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
| opthea.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
| opthea.com. | TXT | 3600 | TXT Record: ppe-344d54514b3af094cd11 |
| opthea.com. | TXT | 3600 | TXT Record: v=spf1 ip4:211.29.132.250 ip4:220.233.0.8 ip4:220.233.0.71 ip4:161.43.65.242 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-04-29 11:08:19
| Hit enter to search or ESC to close Millions of people around the world suffer from impaired vision as a result of diabetes and old age. It’s a growing global problem and Opthea’s mission is clear, To improve their sight to provide them with a better quality of life. LEARN MORE Focus Opthea is committed to improving vision in patients suffering from retinal eye diseases. We are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in combination with existing standard of care anti-VEGF-A therapies. OPT-302 has the potential to address the unmet medical need of wet age-related macular degeneration (AMD) and diabetic macular edema (DME) patients, many of whom respond sub-optimally or become refractory to existing therapies for these debilitating diseases. We are advancing the clinical development of OPT-302 in wet AMD and DME clinical trials. LEARN MORE Disease Wet AMD is the leading cause of blindness in the developed world in people aged over 50 years. It is |
opthea.com Whois Information
Domain Name: OPTHEA.COM Registry Domain ID: 1744081075_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-06-25T08:05:04Z Creation Date: 2012-09-10T23:11:46Z Registry Expiry Date: 2022-09-10T23:11:46Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: ok https://icann.org/epp#ok Name Server: CP-KIL-M-001.M21DNS.NET Name Server: NS2.M21DNS.NET Name Server: NS3.M21DNS.NET Name Server: NS4.M21DNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T00:56:06Z <<< |